Reversible lipidization for the oral delivery of leu-enkephalin

By Wang Jeffrey   Hogenkamp Derk J.   Tran Minhtam   Li Wen-Yen   Yoshimura Ryan F.   Johnstone Timothy B. C.   Shen Wei-Chiang   Gee Kelvin W.  

Journal of Drug Targeting, Vol. 14, Iss. 3, 2006-04 ,pp. : 127-136

Informa Healthcare

Access to resources Recommend Favorite

Antagonistic properties of [Phe 3 ,Leu 13 ]porcine motilin

By Depoortere I.   Macielag M.J.   Galdes A.   Peeters T.L.  

European Journal of Pharmacology, Vol. 286, Iss. 3, 1995-11 ,pp. : 241-247

Elsevier

Access to resources Recommend Favorite

Reversal by [d-Ala 2 ,d-Leu 5 ]enkephalin of the dopamine transporter loss caused by methamphetamine

By Tsao L.-I.   Cadet J.L.   Su T.-P.  

European Journal of Pharmacology, Vol. 372, Iss. 3, 1999-05 ,pp. : 5-7

Elsevier

Access to resources Recommend Favorite

Synthesis and characterization of an acylated di-peptide (Myr-Trp-Leu) with modified transmucosal transport properties

By Veuillez F.   Deshusses J.   Buri P.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 48, Iss. 1, 1999-07 ,pp. : 21-26

Elsevier

Access to resources Recommend Favorite

Chronic [d-Ala 2 , d-Leu 5 ]enkephalin treatment increases the nerve growth factor in adult mouse brain

By Hayashi T.   Su T.-P.  

European Journal of Pharmacology, Vol. 464, Iss. 2, 2003-03 ,pp. : 237-239

Elsevier

Access to resources Recommend Favorite